Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Florida guideFlorida Bids and Bidding Guide
  • Before you submitBid Response: 3 Common Mistakes When Submitting an RFP
More chemical manufacturing bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Florida
  4. ›Chemical Manufacturing
  5. ›RO MEMBRANE SCALE INHIBITOR (ANTISCALANT)

Awarded contract·City of Palm Bay·Florida

RO MEMBRANE SCALE INHIBITOR (ANTISCALANT)

$79kSingle Award
Contract source

Description

The City of Palm Bay is requesting proposals for the purchase and delivery of Reverse Osmosis Membrane Scale Inhibitor – Antiscalant. The estimated annual usage is fifteen 275 gallon totes of product, and pricing is requested per pound. The City expects to order four times per year. The product must meet the minimum specifications detailed in the request. • The City is currently using American Water Chemicals Aquacare A-102. • The estimated annual quantity was factored based on 9.6 lbs. per gallon of product. • Each 275 gallon tote would equal 2,640 lbs. • Proposals must be made on product that can be inspected, accepted and delivered in compliance with the specifications.

Attached files

Key dates

Last updated

Details

Award type
Single Award
Industry
Chemical Manufacturing
NAICS
325000
Solicitation №
12-0-2015

Contract value

$79,200

The estimated annual usage is fifteen 275 gallon totes of product, with each 275 gallon tote equaling 2,640 lbs. Assuming an average price of $2 per pound (which may vary depending on the actual product and supplier), the total estimated annual cost would be 15 * 2,640 * $2 = $79,200. This is a rough estimate and the actual value of the contract may be different.

AI estimate from the award documents

Similar open opportunities

Matched by Bid Banana AI™

LA General Services·California

Top match · 62%

ANTISCALANT (PRETREAT PLUS 0100), MFR. KING LEE TECHNOLOGIES

Closes 11/5/2026Opened 10/30/2026

U.S. Department Of Energy·Ohio

58% match

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

Closes 12/15/2026Opened 6/15/2026

U.S. Department Of Health And Human Services·Indiana

58% match

NOI - B2B Award entitled - Developing Red Cell-Sp

Closes 11/4/2026Opened 10/20/2026

U.S. Department Of Energy·Ohio

56% match

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Closes 12/3/2026Opened 6/4/2026

U.S. National Institutes of Health·United States of America

56% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. Food and Drug Administration·United States of America

56% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Energy·New Mexico

56% match

TIDAL: Target-Induced Droplet Assembly of Ligands

Closes 12/8/2026Opened 9/8/2026

U.S. Department Of Defense·Vermont

55% match

Rivastigmine 24HR Patches

Closes 9/14/2028Opened 9/30/2021

Texas Tx Comm On Environ Quality·Texas

55% match

Membrane Filters

Closes 11/4/2026Opened 10/20/2026

Ohio Department of Rehabilitation and Correction·Ohio

55% match

APEX RAMAN SPECTROMETER - DRC27 - CCI

Closes 11/9/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

55% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. Department Of Defense·New York

55% match

Clobetasol Propionate

Closes 8/28/2029Opened 11/21/2022

St. Tammany Parish Mosquito Abatement District·Louisiana

55% match

#1025 Larvicide and Insecticide Products

Closes 11/13/2026Opened 10/19/2026

U.S. Department Of Defense·United States of America

55% match

Olopatadine HCL 0.1% Ophthalmic Solution

Closes 2/15/2028Opened 6/3/2022

U.S. Food and Drug Administration·United States of America

55% match

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

Rolling / TBD closeOpened 11/5/2024

U.S. Food and Drug Administration·United States of America

54% match

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

Closes 4/1/2027Opened 7/11/2025

U.S. Department Of Health And Human Services·District of Columbia

54% match

Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening

Closes 11/10/2026Opened 10/21/2026

U.S. Department Of Defense·United States of America

54% match

GLAND,ACTUATOR

Closes 11/27/2026Opened 10/28/2026

U.S. Food and Drug Administration·United States of America

54% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

Arkansas Department of Finance and Administration·Arkansas

54% match

Residential Substance Abuse Treatment For State Prisoners Program (RSAT)

Rolling / TBD closeOpened 12/12/2024

U.S. Department Of Defense·United States of America

54% match

Morphine Sulfate Solution

Closes 12/21/2026Opened 9/21/2026

U.S. Department Of Health And Human Services·United States of America

54% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

54% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

U.S. Department Of Health And Human Services·Maryland

54% match

NCSS - Preventative Maintenance Service & Support

Closes 11/11/2026Opened 10/28/2026

U.S. Department Of Defense·Maryland

54% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 9/23/2026